Graphic abstract

Research Paper PKM2 is the Metabolic Checkpoint for Stemness Features in Head and Neck Cancer Wan-Hsuan Sun, Ta-Jung Peng, Hsueh-Jou Fang, Chia-Ling Chang, Yu-Wen Tang, Kuang-Hui Sun J. Cancer 2026; 17(8): 1504-1519. doi:10.7150/jca.132595 Full text PDF


Graphic abstract

Review Field cancerization in urothelial carcinoma: molecular alterations and clinical implications Xinni Ye, Junhao Chen, Hongqiong Li, Haonan Dong, Tianjiao Luo, Peng Chen, Haifeng Wang, Shi Fu J. Cancer 2026; 17(8): 1491-1503. doi:10.7150/jca.125266 Full text PDF


Graphic abstract

Research Paper Mitochondrial Parameters influence Chemosensitivity in Gastric Cancer Cells Kai-Chun Hong, Yi-Chun Chen, You-Syuan Lou, Chia-Chi Tsai, Xu-Chen Liu, Lei-Ni Liang, Chih-Cheng Cheng, Hsin-Hsien Yu, Bor-Chyuan Su J. Cancer 2026; 17(8): 1480-1490. doi:10.7150/jca.137748 Full text PDF


Graphic abstract

Review Environmental co-exposure to microplastics and phenol may influence redox signaling and tumor microenvironment dynamics Chung-Yu Lin, Che-Hsin Lee J. Cancer 2026; 17(8): 1470-1479. doi:10.7150/jca.135514 Full text PDF


Graphic abstract

Research Paper Potential influence of long non-coding RNA NEAT1 genetic variants and expression levels on the progression of prostate cancer Cheng-En Mei, Chia-Yen Lin, Shian-Shiang Wang, Shih-Chi Su, Heng-Hsiung Wu, Lun-Ching Chang, Chih-Hsin Tang, Shun-Fa Yang J. Cancer 2026; 17(8): 1463-1469. doi:10.7150/jca.137994 Full text PDF


Graphic abstract

Review Mitochondrial Dysfunction as a Targetable Vulnerability in Gastric Cancer: From Carcinogenesis to Apoptosis (A Narrative Review) Hsi-Lung Hsieh, Ming-Chin Yu, Hui-Ching Tseng, Yi-Hsuan Wu, Tzu-Hao Huang, Ming-Ming Tsai J. Cancer 2026; 17(8): 1445-1462. doi:10.7150/jca.131081 Full text PDF

More ...

Issue 8; 2026

Cover image

Indexed in PubMed and SCI expanded; full texts in Europe PMC. ...


Mitochondrial Dysfunction as a Targetable Vulnerability in Gastric Cancer: From Carcinogenesis to Apoptosis (A Narrative Review)

Gastric cancer (GC) remains a major global health burden and is associated with high mortality worldwide. Current treatment integrates surgery, perioperative or systemic chemotherapy, molecularly targeted therapy, and immune checkpoint blockade; however, efficacy is frequently limited by intratumoral heterogeneity, metabolic plasticity, and therapeutic resistance. Mitochondria, as central regulators of cellular bioenergetics, redox homeostasis, and ...


Field cancerization in urothelial carcinoma: molecular alterations and clinical implications

Urothelial carcinoma (UC) is a common malignancy of the urinary tract and is characterized by frequent recurrence, particularly in patients with non-muscle-invasive disease. Recurrence has traditionally been explained by residual tumor cells, intraluminal seeding, or the outgrowth of disseminated clones. However, molecular studies have shown that urothelium that appears normal under routine histological examination may already harbor cancer-related ...

Popup Image